Market Cap 1.21B
Revenue (ttm) 203.07M
Net Income (ttm) -54.84M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -27.01%
Debt to Equity Ratio -255.20
Volume 781,000
Avg Vol 2,515,126
Day's Range N/A - N/A
Shares Out 165.92M
Stochastic %K 53%
Beta 0.57
Analysts Strong Sell
Price Target $11.14

Company Profile

Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the...

Industry: Biotechnology
Sector: Healthcare
Phone: 844 445 5704
Address:
1375 West Fulton Street, Suite 1300, Chicago, United States
BullRaptor
BullRaptor Dec. 24 at 6:23 PM
$XERS Merry Christmas longs !
0 · Reply
TymeTryethTroth
TymeTryethTroth Dec. 24 at 5:47 PM
$XERS Merry Christmas XERS friends. I hope each of you have a great time with family and friends. Here’s to another great year for Xeris in 2026!
1 · Reply
Ithaca2018
Ithaca2018 Dec. 24 at 5:43 PM
$XERS Wishing my XERS Family a Beautiful Holiday Season filled with wonderful surprises for 2026. Remember, a dream is wish your heart makes🧜‍♀️
0 · Reply
SparkyReturns
SparkyReturns Dec. 24 at 5:05 PM
$XERS Merry Christmas Xeris Fam! Just realized we've doubled in value since this time last year! We'll be back over 10 before long. Enjoy time with friends and family, and may your holidays be bright! There are so many people on here that I appreciate for your research and insights that it would be hard to list, but you know who you are! Cheers! The ride continues! BTW I wanna be like this guy when I grow up. https://www.youtube.com/watch?v=yDRJItKqClk
1 · Reply
ForTGTX
ForTGTX Dec. 24 at 3:51 PM
$XERS Who is still suppressing this gem?? We should break this $7 wall and go back up to 10s soon. Merry Christmas to you guys 🎄🎁
0 · Reply
dave2ta
dave2ta Dec. 24 at 3:46 PM
$XERS Here is the conclusion: 🎯 Most realistic public availability window Based on the above: 👉 XP‑8121 could realistically reach the market in 2028–2029. This is the earliest credible window given: • Completed Phase 2 • Strong early clinical enthusiasm • No Phase 3 start yet • Standard FDA timelines 🧠 Why this timeline makes sense XP‑8121 is not a high‑risk drug — it’s a reformulation of levothyroxine using Xeris’ XeriJect technology. That means: • Lower clinical risk • High probability of Phase 3 success • But still requires full Phase 3 + FDA review The biggest variable is when Xeris officially launches Phase 3, which could be announced at: • Earnings calls • Investor Day • A press release tied to funding or partnership
1 · Reply
dave2ta
dave2ta Dec. 24 at 3:45 PM
$XERS I just had a long chat with my friend "Copilot" about $XERS . One of the things we talked about was XP-8121 and when it may come out of Phase 3 and become available to the Public. His Timeline was exactly the same as mine, 2028 - 2029... Here is what he had to say: 🧭 Typical timeline for a drug at this stage XP‑8121 is a once‑weekly levothyroxine injection, which is an endocrine therapy — not oncology, not gene therapy. That means: • Phase 3 trials are large, but not multi‑year mega‑trials. • Endocrine Phase 3 programs typically take 18–30 months. • FDA review (NDA submission → approval) typically takes 10–12 months. So the timeline looks like this: 📅 Projected XP‑8121 Timeline (Based on Industry Norms) Phase 3 Start: Likely 2026 (They are already spending more R&D on XP‑8121 and have completed dose‑conversion work.) Phase 3 Duration: 18–24 months Endocrine trials usually require long‑term stability data. NDA Submission: Late 2027 – mid‑2028 FDA Review: 10–12 months
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 24 at 2:26 PM
Enter: $XERS Calls Strike Price: $8 Expiry Date: JAN 16 2026 Buy in Price: $0.42 - $0.44 Sell Price: $0.80 Profit : +90% (Turn every $1 into $1.90) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
1 · Reply
Scottyknowsall
Scottyknowsall Dec. 24 at 2:23 AM
$XERS tomorrow we go green again. Lets finish the year strong mighty mighty XERS!!!!!
0 · Reply
BuyThisOne
BuyThisOne Dec. 24 at 1:48 AM
$XERS Holding pattern until probably late January, early Feb until we start to climb into the earnings call in the first week of March. Should be a very interesting year. We will most likely have a positive EPS moving forward but it is very hard to say how hard the trial costs will hit in Q3 and Q4 next year on how high those will go. We already hit $10 on the prospect of a penny EPS so I think $12 should be pretty easy to see in 2026 and maybe a little higher. My long term targets were $4, $8, $16 and $32 for 2024, 2025, 2026 and 2027 respectively. 2 for 4 so far on those. Lets see if I can go 4 for 4. I will be more than happy with $12 next year and about $20 for 2027. That is still 10x in ~4 years depending on when you bought/average.
0 · Reply
Latest News on XERS
Xeris In Recorlev-Fuelled Growth: Why I Choose To Buy

Sep 5, 2025, 10:03 AM EDT - 3 months ago

Xeris In Recorlev-Fuelled Growth: Why I Choose To Buy


Xeris Announces Details for Analyst & Investor Day

May 20, 2025, 7:30 AM EDT - 7 months ago

Xeris Announces Details for Analyst & Investor Day


Xeris Biopharma Holdings: Looking For More Growth In Q1 Earnings

May 7, 2025, 11:51 AM EDT - 8 months ago

Xeris Biopharma Holdings: Looking For More Growth In Q1 Earnings


Xeris Announces Changes to Its Board of Directors

Mar 28, 2025, 8:00 AM EDT - 9 months ago

Xeris Announces Changes to Its Board of Directors


Xeris Appoints Anh Nguyen, MD, MBA as Chief Medical Officer

Feb 24, 2025, 8:00 AM EST - 10 months ago

Xeris Appoints Anh Nguyen, MD, MBA as Chief Medical Officer


Xeris to Participate in Upcoming Investor Conferences

Feb 5, 2025, 8:00 AM EST - 11 months ago

Xeris to Participate in Upcoming Investor Conferences


Xeris Expects to Exceed Full-Year 2024 Financial Guidance

Jan 10, 2025, 7:00 AM EST - 1 year ago

Xeris Expects to Exceed Full-Year 2024 Financial Guidance


Xeris Biopharma Reports Third Quarter 2024 Financial Results

Nov 8, 2024, 7:00 AM EST - 1 year ago

Xeris Biopharma Reports Third Quarter 2024 Financial Results


Xeris Biopharma: Time For A Reassessment

Oct 9, 2024, 11:33 AM EDT - 1 year ago

Xeris Biopharma: Time For A Reassessment


Xeris Biopharma Announces CEO Succession Plan

Jul 8, 2024, 7:00 AM EDT - 1 year ago

Xeris Biopharma Announces CEO Succession Plan


Xeris Biopharma: Checking-In On One Of My 'Top Ideas'

Mar 30, 2024, 1:28 AM EDT - 1 year ago

Xeris Biopharma: Checking-In On One Of My 'Top Ideas'


Xeris Biopharma (XERS) Q4 2023 Earnings Call Transcript

Mar 6, 2024, 12:43 PM EST - 1 year ago

Xeris Biopharma (XERS) Q4 2023 Earnings Call Transcript


BullRaptor
BullRaptor Dec. 24 at 6:23 PM
$XERS Merry Christmas longs !
0 · Reply
TymeTryethTroth
TymeTryethTroth Dec. 24 at 5:47 PM
$XERS Merry Christmas XERS friends. I hope each of you have a great time with family and friends. Here’s to another great year for Xeris in 2026!
1 · Reply
Ithaca2018
Ithaca2018 Dec. 24 at 5:43 PM
$XERS Wishing my XERS Family a Beautiful Holiday Season filled with wonderful surprises for 2026. Remember, a dream is wish your heart makes🧜‍♀️
0 · Reply
SparkyReturns
SparkyReturns Dec. 24 at 5:05 PM
$XERS Merry Christmas Xeris Fam! Just realized we've doubled in value since this time last year! We'll be back over 10 before long. Enjoy time with friends and family, and may your holidays be bright! There are so many people on here that I appreciate for your research and insights that it would be hard to list, but you know who you are! Cheers! The ride continues! BTW I wanna be like this guy when I grow up. https://www.youtube.com/watch?v=yDRJItKqClk
1 · Reply
ForTGTX
ForTGTX Dec. 24 at 3:51 PM
$XERS Who is still suppressing this gem?? We should break this $7 wall and go back up to 10s soon. Merry Christmas to you guys 🎄🎁
0 · Reply
dave2ta
dave2ta Dec. 24 at 3:46 PM
$XERS Here is the conclusion: 🎯 Most realistic public availability window Based on the above: 👉 XP‑8121 could realistically reach the market in 2028–2029. This is the earliest credible window given: • Completed Phase 2 • Strong early clinical enthusiasm • No Phase 3 start yet • Standard FDA timelines 🧠 Why this timeline makes sense XP‑8121 is not a high‑risk drug — it’s a reformulation of levothyroxine using Xeris’ XeriJect technology. That means: • Lower clinical risk • High probability of Phase 3 success • But still requires full Phase 3 + FDA review The biggest variable is when Xeris officially launches Phase 3, which could be announced at: • Earnings calls • Investor Day • A press release tied to funding or partnership
1 · Reply
dave2ta
dave2ta Dec. 24 at 3:45 PM
$XERS I just had a long chat with my friend "Copilot" about $XERS . One of the things we talked about was XP-8121 and when it may come out of Phase 3 and become available to the Public. His Timeline was exactly the same as mine, 2028 - 2029... Here is what he had to say: 🧭 Typical timeline for a drug at this stage XP‑8121 is a once‑weekly levothyroxine injection, which is an endocrine therapy — not oncology, not gene therapy. That means: • Phase 3 trials are large, but not multi‑year mega‑trials. • Endocrine Phase 3 programs typically take 18–30 months. • FDA review (NDA submission → approval) typically takes 10–12 months. So the timeline looks like this: 📅 Projected XP‑8121 Timeline (Based on Industry Norms) Phase 3 Start: Likely 2026 (They are already spending more R&D on XP‑8121 and have completed dose‑conversion work.) Phase 3 Duration: 18–24 months Endocrine trials usually require long‑term stability data. NDA Submission: Late 2027 – mid‑2028 FDA Review: 10–12 months
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 24 at 2:26 PM
Enter: $XERS Calls Strike Price: $8 Expiry Date: JAN 16 2026 Buy in Price: $0.42 - $0.44 Sell Price: $0.80 Profit : +90% (Turn every $1 into $1.90) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
1 · Reply
Scottyknowsall
Scottyknowsall Dec. 24 at 2:23 AM
$XERS tomorrow we go green again. Lets finish the year strong mighty mighty XERS!!!!!
0 · Reply
BuyThisOne
BuyThisOne Dec. 24 at 1:48 AM
$XERS Holding pattern until probably late January, early Feb until we start to climb into the earnings call in the first week of March. Should be a very interesting year. We will most likely have a positive EPS moving forward but it is very hard to say how hard the trial costs will hit in Q3 and Q4 next year on how high those will go. We already hit $10 on the prospect of a penny EPS so I think $12 should be pretty easy to see in 2026 and maybe a little higher. My long term targets were $4, $8, $16 and $32 for 2024, 2025, 2026 and 2027 respectively. 2 for 4 so far on those. Lets see if I can go 4 for 4. I will be more than happy with $12 next year and about $20 for 2027. That is still 10x in ~4 years depending on when you bought/average.
0 · Reply
Sam_Cutcher
Sam_Cutcher Dec. 24 at 12:01 AM
$XERS We are still climbing towards 7.30$, after a crowded day. This indicates some weakness, that can have a negative influence on future price. Time will tell. I recommend you to have an eye on this stock for the upcoming months . I wish you all a "Merry Christmas"!
3 · Reply
n9zro
n9zro Dec. 23 at 11:22 PM
$XERS Hey where is @Universaal ? Is he now @Sam Cutcher?
1 · Reply
StarF
StarF Dec. 23 at 10:22 PM
$XERS whats with the high volume after market close?
1 · Reply
n9zro
n9zro Dec. 23 at 9:15 PM
$XERS @Sam_Cutcher How ya doing ?
0 · Reply
gimoozaabi
gimoozaabi Dec. 23 at 7:29 PM
$XERS Happy Holidays OGs. I’ve been on the cruise mode since the last ER, just nibbling a few, as the budget allows. See you all in 2026 as we continue another 1-200% and hopefully several good surprises along with the expected milestones.
0 · Reply
ForTGTX
ForTGTX Dec. 23 at 6:47 PM
1 · Reply
Scottyknowsall
Scottyknowsall Dec. 23 at 5:07 PM
$XERS we're gonna finish green today, i can feel it in my bones. LFG !! Good luck longs
0 · Reply
BuyThisOne
BuyThisOne Dec. 23 at 4:13 PM
$XERS This is what my ghost of Christmas future showed me last night. I got a nice chunk of shares at $1.07 and my overall average is somewhere around $2.20 If we get to $40 in 2030 this is what that looks like. Just in case you wonder why I don't really care about the price movement in the short term. Just like the ups only being on paper the same is true of the dips. I have always been extremely long on this stock, out to at least the early to mid 2030's. Do your own research and have a plan here otherwise you might just miss out on one of the best opportunities of your life. If this dips after Relacorilant approval next week it might just be the opportunity a lot missed a little bit back.
0 · Reply
ShortsHater
ShortsHater Dec. 23 at 3:56 PM
0 · Reply
pascallambrecht
pascallambrecht Dec. 23 at 3:18 PM
$XERS we need uptrend difficul
0 · Reply
StarF
StarF Dec. 23 at 3:06 PM
$XERS jfc i hope this fustration and pain is worth the wait... good christmas/yule or what ever to everyone...
1 · Reply
mendryl2
mendryl2 Dec. 23 at 2:41 PM
$XERS up 33 cents the other day bleed off after. oh well. still think we bounce january.
1 · Reply